Article

House Panel Examines Nuts and Bolts Of Changing Traditional Medicare

Outside of the heat of election season, a House subcommittee chaired by Rep. Kevin Brady, began examining options Tuesday for cost savings in traditional Medicare. KHN's Mary Agnes Carey and Jackie Judd discuss the proceedings. [Listen To The Audio]

Listen to the full story: http://bit.ly/YwAv72

Source: Kaiser Health News

Related Videos
John Barkett, MBA
Emma Achola-Kothari, PhD
Dr Emma Achola-Kothani
Dr Emma Achola-Kothari
John Barkett, MBA
John Barkett, MBA
Tom Belmont
Dr Mingyang Song
John Michael O'Brien, PharmD, MPH
Related Content
Pediatrician test results tablet parent child - nimito - stock.adobe.com
May 23rd 2025

MAHA Report Calls for Whole-of-Government Action to Solve Childhood Health Crisis

Giuliana Grossi
The Make Our Children Healthy Again assessment from the Make America Healthy Again (MAHA) Commission warns of a national childhood health crisis and calls for broad federal reforms.
managed care cast logo
April 22nd 2025

New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix

Brooke McCormick Brady Post, PhD
On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Pill bottle with money inside | Image credit: Kenishirotie - stock.adobe.com
May 20th 2025

HHS Sets Pricing Target for Trump’s Most Favored Nation Drug Price Model

Laura Joszt, MA
Following President Donald Trump's most favored nation executive order, HHS and CMS have released the target price for pharmaceutical manufacturers to meet.
managed care cast logo
February 18th 2025

Varied Access: The Pharmacogenetic Testing Coverage Divide

Brooke McCormick Jai N. Patel, PharmD
On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
FDA | Image credit: Postmodern Studio
May 20th 2025

Is the US Headed for an Infectious Disease Pandemic?

Giuliana Grossi
In an era that FDA Commissioner Marty Makary, MD, MPH, calls an "epidemic of distrust" toward health institutions, previously contained disease rates are rapidly rising, and vaccination rates are proceeding in the opposite direction.
MedicarePartD | Image Credit: © driftwood-stock.adobe.com
May 16th 2025

Specialty Drug Users to Gain Relief Under Medicare Reforms

Maggie L. Shaw
A new analysis looked at estimated out-of-pocket costs for etanercept, ustekinumab, and ibrutinib, specialty drugs that often represent a significant cost burden for Medicare Part D beneficiaries and which were selected for 2026 drug price negotiation under the Inflation Reduction Act.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo